Latham & Watkins has advised global biopharma company GSK on a US$110 million research collaboration with Relation Therapeutics, an end-to-end biotech developing transformational medicine.
Under the collaboration, GSK and Relation Therapeutics will generate large-scale human cellular datasets which would be used to train artificial intelligence foundational models for use in drug discovery. The collaboration builds on earlier partnerships between the companies focused on fibrotic disease and osteoarthritis.
The Latham team was led by London partner Lydia Torne, with associate Luke Nauth.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
